Alder BioPharmaceuticals, Inc. EPS - Earnings per Share 2014-2019 | ALDR
Alder BioPharmaceuticals, Inc. eps - earnings per share from 2014 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Alder BioPharmaceuticals, Inc. Annual EPS |
| 2018 |
$-4.87 |
| 2017 |
$-4.95 |
| 2016 |
$-3.23 |
| 2015 |
$-2.11 |
| 2014 |
$0.30 |
| 2013 |
$-21.14 |
| 2012 |
$-19.54 |
| Alder BioPharmaceuticals, Inc. Quarterly EPS |
| 2019-06-30 |
$-0.72 |
| 2019-03-31 |
$-1.63 |
| 2018-12-31 |
$-1.19 |
| 2018-09-30 |
$-0.91 |
| 2018-06-30 |
$-1.04 |
| 2018-03-31 |
$-1.73 |
| 2017-12-31 |
$-0.56 |
| 2017-09-30 |
$-0.92 |
| 2017-06-30 |
$-1.48 |
| 2017-03-31 |
$-1.99 |
| 2016-12-31 |
$-0.98 |
| 2016-09-30 |
$-0.70 |
| 2016-06-30 |
$-0.79 |
| 2016-03-31 |
$-0.76 |
| 2015-12-31 |
$-0.63 |
| 2015-09-30 |
$-0.62 |
| 2015-06-30 |
$-0.46 |
| 2015-03-31 |
$-0.40 |
| 2014-12-31 |
$5.20 |
| 2014-09-30 |
$0.88 |
| 2014-06-30 |
$-0.40 |
| 2014-03-31 |
$-5.38 |
| 2013-12-31 |
$-3.93 |
| 2013-09-30 |
$-6.05 |
| 2013-06-30 |
$-5.27 |
| 2013-03-31 |
$-5.89 |
